Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Cost of Revenue (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Cost of Revenue for 2 consecutive years, with -$7.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 150.28% to -$7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $856000.0, a N/A change, with the full-year FY2025 number at $856000.0, changed N/A from a year prior.
  • Cost of Revenue was -$7.2 million for Q4 2025 at Nuvation Bio, down from $3.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $3.3 million in Q3 2025 to a low of -$7.2 million in Q4 2025.